Stem Cell Transplant

·MeSH: Medication Adherence

24 drugs in development·15 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
evomela	CASI Pharmaceuticals, Inc (DE) (CASI)
fulphila	Mylan II B.V. (MYL)
lenalidomide	Mylan II B.V. (MYL)
Monjuvi	Xencor Inc (XNCR)
Prevymis	Merck & Co., Inc. (MRK)
yartemlea	OMEROS CORP (OMER)

Phase 3(4)

Drug	Company
nomacopan	Akari Therapeutics Plc (AKTX)
posoleucel	Kalaris Therapeutics, Inc. (KLRS)
Tacrolimus	Filana Therapeutics Inc. (FLNA)
Unrelated donor bone marrow transplant	Filana Therapeutics Inc. (FLNA)

Phase 2(8)

Drug	Company
Bortezomib	Coeptis Therapeutics Holdings Inc. (COEP)
Daratumumab	Coeptis Therapeutics Holdings Inc. (COEP)
G-CSF	PTC THERAPEUTICS, INC. (PTCT)
GPC-100	PTC THERAPEUTICS, INC. (PTCT)
Haploidentical donor bone marrow transplant	Filana Therapeutics Inc. (FLNA)
narsoplimab	OMEROS CORP (OMER)
nexi-001	NexImmune, Inc. (NEXI)
Propranolol	PTC THERAPEUTICS, INC. (PTCT)

Phase 1(2)

Drug	Company
TAK-079	Merus N.V. (MRUS)
Veto Cell	Cell Source, Inc. (CLCS)

Preclinical(3)

Drug	Company
Anti-Rejection Anti-Viral Veto Cell	Cell Source, Inc. (CLCS)
fsi-174	Forty Seven, Inc. (FTSV)
Veto Cell technology	Cell Source, Inc. (CLCS)

Phase 4(1)

Drug	Company
plerixafor + g-csf	Sanofi (SNY)

BioSniper tracks 24 drugs in development for Stem Cell Transplant across 15 companies.

There are 1 clinical trial targeting Stem Cell Transplant tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.